Founders Capital Management (Texas)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-47
| Closed | -$910 | – | 383 |
|
|
2024
Q3 | $910 | Hold |
47
| – | – | ﹤0.01% | 348 |
|
|
2024
Q2 | $868 | Hold |
47
| – | – | ﹤0.01% | 348 |
|
|
2024
Q1 | $654 | Hold |
47
| – | – | ﹤0.01% | 341 |
|
|
2023
Q4 | $396 | Sell |
47
-53
| -53% | -$447 | ﹤0.01% | 370 |
|
|
2023
Q3 | $893 | Hold |
100
| – | – | ﹤0.01% | 382 |
|
|
2023
Q2 | $863 | Hold |
100
| – | – | ﹤0.01% | 371 |
|
|
2023
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 377 |
|
|
2022
Q4 | $3K | Sell |
100
-33
| -25% | -$990 | ﹤0.01% | 351 |
|
|
2022
Q3 | $6K | Hold |
133
| – | – | ﹤0.01% | 332 |
|
|
2022
Q2 | $8K | Buy |
133
+66
| +99% | +$3.97K | 0.01% | 341 |
|
|
2022
Q1 | $14K | Hold |
67
| – | – | 0.01% | 245 |
|
|
2021
Q4 | $14K | Buy |
+67
| New | +$14K | 0.01% | 245 |
|